XXI Wealth LLC’s Colgate-Palmolive CL Stock Holding History

XXI Wealth LLC’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$284K	Buy	3,101 +458	+17%	+$40.1K	0.13%	178
2026 Q1	$225K	Sell	2,643 -193	-7%	-$17.2K	0.13%	187
2025 Q4	$224K	Buy	+2,836	New	+$222K	0.14%	167

Other funds holding CL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

XXI Wealth LLC's CL Position: Q2 2026 in Review

XXI Wealth LLC increased its Colgate-Palmolive (CL) stake by 17% in Q2 2026, buying an estimated $40.1K and bringing the position to 3,101 shares worth $284K. The position accounts for 0.13% of the portfolio, ranked #178.

XXI Wealth LLC first reported a position in CL in Q4 2025 and has held it in 3 quarters since. 2,013 funds tracked by Wall St. Rank hold CL as of Q2 2026.

XXI Wealth LLC held 3,101 shares of Colgate-Palmolive worth $284K as of Q2 2026.
XXI Wealth LLC bought 458 Colgate-Palmolive shares in Q2 2026, an estimated $40.1K.
Colgate-Palmolive made up 0.13% of XXI Wealth LLC's portfolio in Q2 2026, its #178 holding.
XXI Wealth LLC first reported a position in Colgate-Palmolive in Q4 2025 and has held it in 3 quarters since.
2,013 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on XXI Wealth LLC's 13F filing for Q2 2026, filed 14 Aug 2026.